Credit Suisse’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.56M | Sell |
|
|||||
|
2023
Q3 | $2.41M | Sell |
|
|||||
|
2023
Q2 | $1.88M | Buy |
|
|||||
|
2023
Q1 | $573K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $160K | Sell |
|
|||||
|
2020
Q4 | $226K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.71M | Sell |
|
|||||
|
2020
Q1 | $907K | Buy |
|
|||||
|
2019
Q4 | $70K | Sell |
|
|||||
|
2019
Q3 | $238K | Buy |
|
|||||
|
2019
Q2 | $311K | Sell |
|
|||||
|
2019
Q1 | $11M | Buy |
|
|||||
|
2018
Q4 | $319K | Sell |
|
|||||
|
2018
Q3 | $453K | Sell |
|
|||||
|
2018
Q2 | $780K | Buy |
|
|||||
|
2018
Q1 | $279K | Sell |
|
|||||
|
2017
Q4 | $271K | Buy |
|
|||||
|
2017
Q3 | $127K | Buy |
|